BioMarin Pharmaceuti...
NasdaqGS:BMRN
$ 61,12
+ $0,55 (0,91%)
61,12 $
+$0,55 (0,91%)
End-of-day quote: 03/06/2026

Quick Analysis

The quick analysis data is updated as follows:

  • G (Growth Rate): Every 3 months when the company releases quarterly figures.
  • R (Risk Analysis): Every 12 months when the company publishes its annual financial statements.
  • O (Outlook): At the daily closing price.
  • W (Margin of safety): At the daily closing price.
  • T (Analyst Price Target): At the daily closing price.
  • H (Trend): At the weekly closing price.

A word about the trend:

The trend is not updated daily, as the GROWTH strategy is based on weekly prices. If necessary, you can check the valuation chart to see if the price has broken the daily trend.

G
12,22%
5-year Growth Rate
R
5/6
5-year Risk Analysis
O
45,49%
Outlook 12/26
W
53,83%
Margin of safety
T
53,80%
Analyst Price Target
H
UP
50-week EMA Trend

Company Info

EPS Growth 5Y
14,08%
Revenue growth 5Y
10,36%
Price growth 5Y
-20,39%
Market Cap
$11,76 B
Long-Term Debt
$0,60 B
Short Interest
3,99%
Quarterly earnings
04/24/2026
Dividend
$0,00
Dividend Yield
0,00%
Industry
ISIN Number

BioMarin Pharmaceutical Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target

$94,00
53.8%
53.8
Last Update: 03/05/2026
Analysts: 23

Highest Price Target $120,00

Average Price Target $94,00

Lowest Price Target $55,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
BioMarin Pharmaceutical
NasdaqGS:BMRN
-20,39% -20,39% 0,00% 12,22% 5/6 45,49% 53,83% 53,80% UP
×